Senopi

What Senopi does

Senopi AG is a Switzerland-based digital health company that develops virtual reality (VR) solutions for the physical and mental health of senior populations. The company offers two core products: SenopiMed, a VR headset-based motor-cognitive therapy system that combines upper-body physical exercises with cognitive challenges, complemented by a smartphone/tablet/desktop monitoring application for caregivers and therapists; and SenopiCare, a tablet-based application delivering 360-degree virtual excursions to care institution residents. The technology stack is built on consumer VR hardware paired with proprietary interactive therapy content and a remote session-monitoring application, with no disclosed AI/ML or model-based personalization layer. SenopiMed is clinically validated through a 130-participant study registered as NCT05369897, with results published in JMIR Preprints and Research Square.

The company was incubated within Ricola's corporate innovation lab (Ricolab) starting in 2018 and was incorporated as Senopi AG in Switzerland. It operates a direct sales-led go-to-market targeting care homes and healthcare institutions, with quote-based enterprise pricing on annual subscription terms and hardware sales for the SenopiMed VR system. Customers are primarily Swiss care institutions and the healthcare professionals serving seniors with mild cognitive impairment, dementia, or physical limitations. The company has conducted usability studies and pilots with partners including MUL university, TerzStiftung, Cato Senteret, Akademie Berlingen, the City of Helsinki, and the AAL programme, and has technology integrations with SensoryX and HealthTunes. Geographic reach is currently regional (Switzerland) with limited international pilot activity, and the company has 1-10 employees with no disclosed external funding, revenue, or institutional investors.

Name

Senopi

Legal name

Senopi AG

Website

https://senopi.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Senopi AG develops VR-based motor-cognitive therapy solutions for seniors, offering a clinically validated VR headset therapy system (SenopiMed) and a tablet-based virtual excursion application (SenopiCare) to care institutions and healthcare professionals primarily in Switzerland.

Ownership category

akta.pro rank

Product category

Digital Health / Virtual Reality Therapy

NAICS

Home Health Care Services (6216), Assisted Living Facilities for the Elderly (623312)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH)

akta.pro secondary industries

Cognitive-Communication & Memory Rehab Therapy In-Home (HSABADAL), Dementia Personal Care (ADLs) Support (HSABAEAB)

Keywords

• VR motor-cognitive therapy
• Senior care VR
• Virtual reality healthcare
• Digital therapeutics seniors
• MCI dementia therapy

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. SenopiMed VR System: Sale of VR headset hardware combined with motor-cognitive therapy software subscription for healthcare facilities providing therapy to seniors.
2. SenopiCare Platform: Tablet-based VR experience platform for care institutions, likely sold as a subscription or one-time license to healthcare facilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Senopi develops and sells VR-based therapeutic products for seniors, primarily SenopiMed (a VR headset-based motor-cognitive therapy system combining physical upper-body training with cognitive exercises) and SenopiCare (a tablet-based virtual reality application providing 360-degree excursions for care institutions). The products target healthcare facilities and at-home users to deliver evidence-based, clinician-validated therapy for seniors including those with mild cognitive impairment and dementia.

Product overview

Senopi offers two distinct VR-based therapeutic products: SenopiMed (a clinically validated motor-cognitive therapy delivered via VR headset for seniors in care facilities and at home) and SenopiCare (a tablet-based virtual excursion application for care institutions). Both products target senior populations, with SenopiMed focusing on cognitive training and physical therapy, while SenopiCare provides immersive virtual travel experiences to stimulate memory and conversation.

Differentiator

Problem solved

Functional benefit

Brands

• SenopiMed: VR headset-based motor-cognitive therapy solution providing interactive training for seniors to train upper body and cognition. Clinically validated with customizable user difficulty levels.
• SenopiCare

Products and services

• SenopiMed Clinically validated VR headset-based motor-cognitive therapy solution that provides interactive training combining physical exercise (upper body) with cognitive challenges for seniors, including those with mild cognitive impairment or dementia. Includes an accompanying smartphone, tablet and desktop app for therapy setup, remote control and post-session monitoring.
• SenopiCare Tablet-based virtual reality application enabling care institutions to provide virtual excursions to residents through 360-degree videos of familiar and new destinations. Designed for healthy seniors, people with mild cognitive impairment, and people with physical impairment to stimulate memory, reminiscence and social engagement.

Quantifiable outcome

• Meta-analysis of 17 controlled trials shows positive effects on global cognition, attention, working memory, learning and memory in older adults with MCI
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Ricola (Ricolab)coreStrategic or Co-development Partner · 1 January 2018Ricola's innovation lab (Ricolab) where Senopi was originally developed since 2018. This is the founding partnership that spawned the company, with Senopi AG spun off from Ricola's R&D efforts in senior care VR technology.
• MULcoreStrategic or Co-development PartnerUniversity partner involved in product development and testing. Collaborated on usability studies from August 2021 to April 2023.
• Cato SenteretminorStrategic or Co-development PartnerPartner in pilot study (August-December 2023) exploring SenopiMed for fall risk prevention with 10 high-functioning older adults.
• TerzStiftungminorStrategic or Co-development PartnerFoundation partner supporting usability studies (August 2021 to April 2023) with 10-20 seniors.
• Akademie BerlingenminorStrategic or Co-development PartnerEducational institution partner involved in product development collaboration.
• City of HelsinkiminorStrategic or Co-development PartnerCity government partner for pilot test (2020) of SenopiCare with healthy seniors and those with memory disorders.
• AALminorStrategic or Co-development PartnerActive and Assisted Living programme partner supporting development efforts.
• IMDminorStrategic or Co-development PartnerInternational Institute for Management Development - strategic partner in product development ecosystem.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Rendever: US-based VR platform purpose-built for senior living communities, offering immersive shared experiences (including virtual travel and reminiscence content) for older adults. Most directly comparable to SenopiCare's 360-degree virtual excursion use case in care facilities.
• XRHealth: VR-based telehealth therapy platform delivering clinician-supervised motor and cognitive rehabilitation in patients' homes and clinics. Closely comparable to SenopiMed in combining physical/cognitive VR exercises with a remote-monitoring clinician app.
• It's Never 2 Late (iN2L): Senior-engagement technology platform deployed in thousands of US skilled-nursing and assisted-living communities, combining touchscreen content, reminiscence, and virtual experiences. Comparable to SenopiCare as a resident-engagement/quality-of-life product sold to care facilities.
• BehaVR: VR-based digital therapeutics company building clinically validated immersive therapies for behavioral and mental health conditions. Comparable to SenopiMed in combining clinically validated VR protocols with adaptive difficulty and remote clinician monitoring.
• Constant Therapy Health: Digital speech, language, and cognitive therapy platform prescribed by clinicians for stroke, TBI, and dementia patients. Comparable to SenopiMed in delivering adaptive cognitive/motor exercises with clinician dashboards, though delivered via tablet/web rather than VR headset.

Broad incumbents

• MindMaze: Well-funded Swiss-founded VR neuro-rehabilitation platform with FDA-cleared products for motor and cognitive recovery in stroke and brain-injury patients. A larger, established peer operating in clinical-grade VR neurorehab — overlapping with SenopiMed's motor-cognitive focus but at a different scale and regulatory bar.
• Posit Science (BrainHQ): Established, evidence-based cognitive training platform with extensive clinical trials in older adults, including MCI and dementia. Comparable in evidence-based senior cognitive training, though delivered as a computer/web program rather than immersive VR.
• CogniFit: Cognitive assessment and training platform with a large library of brain-training exercises targeting memory, attention, and motor-cognitive skills. Comparable to the cognitive component of SenopiMed, though without the immersive VR or upper-body physical training element.

Emerging players

• MyndYou: AI-driven platform for remote cognitive monitoring and personalized engagement of older adults, including those with MCI and dementia. Comparable as a technology-enabled cognitive-care solution for the same senior population, though delivered via AI voice/conversational interface rather than VR.
• NeuroNation: Science-based brain-training app with exercises targeting memory, attention, and reasoning in older adults. Comparable in evidence-based cognitive training for seniors, though consumer-direct and non-VR rather than facility-deployed immersive therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/senopi
• Facebookfacebook.com/Senopi-113388410321967

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Senopi